Nascent Pharma Holdings, Inc.
NASC
$0.02
$0.00-8.33%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -3.26M | -3.14M | -5.05M | -1.81M | -4.17M |
| Total Depreciation and Amortization | 0.00 | 29.20K | 314.40K | 350.00K | 351.20K |
| Total Amortization of Deferred Charges | 145.30K | 103.60K | 239.80K | 895.30K | 143.70K |
| Total Other Non-Cash Items | 2.55M | 1.89M | 3.25M | 1.93M | 2.59M |
| Change in Net Operating Assets | 572.40K | 985.80K | 1.46M | -1.22M | 869.40K |
| Cash from Operations | 9.10K | -131.10K | 217.00K | 151.40K | -206.60K |
| Capital Expenditure | -- | -- | -- | 0.00 | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -6.50K | -3.90K | -- | 400.00 | 0.00 |
| Cash from Investing | -6.50K | -3.90K | -- | 400.00 | 0.00 |
| Total Debt Issued | 9.00K | 132.60K | 109.00K | 159.00K | 124.00K |
| Total Debt Repaid | -3.70K | -24.40K | -333.30K | -308.10K | -9.50K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 0.00 | 0.00 |
| Cash from Financing | 5.30K | 108.20K | -224.30K | -149.10K | 114.50K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | 100.00 | -100.00 | -- | 0.00 |
| Net Change in Cash | 7.90K | -26.60K | -7.40K | 2.70K | -92.10K |